SUMMARY Since 2020, three UK-based organisations, Medicines Discovery Catapult, MND Association and My Name’5 Doddie Foundation, have been working together to galvanise the cross-sector ALS research community to identify key opportunities and challenges to accelerating drug discovery. A key challenge identified was the need for more consensus on what constitutes a robust preclinical pathway and data package in ALS. To